Table 2.

Institutional surgical triage schemas for urologic malignancies

Cancer Type/Stage	Duke University [10]	Guy's and St. Thomas’ [14]	Dana-Farber/Brigham and Women's [15]
Renal
cT1-2	• T1—low priority • T2—intermediate priority	• Nephrectomy (time-sensitive) last to be cancelled	• Defer surgery until normal services resume
≥cT3	• Highest priority	• Last to be cancelled	• Perform surgery without delay
Adrenal	• >3 cm tumors—high priority • <3 cm tumors—intermediate priority	N/A	N/A
UTUC	• Ta/T1 low or high grade—Intermediate priority • T2—high priority	• Nephroureterectomy for low risk—second cancellation tier • High-risk disease—last to be cancelled	N/A
Bladder	• Intermediate risk NMIBC—low priority • High-risk NMIBC—intermediate priority • MIBC—high priority	• Cystectomy for low-risk cancer—second cancellation tier • High risk disease—last to be cancelled	• Cystectomy within 8 weeks of neoadjuvant chemotherapy
Prostate	• Intermediate risk, <6 mo wait—low priority • High risk, <6 mo wait or Intermediate risk, >6 mo wait—Intermediate priority • High risk, >6 mo wait- high priority	• High cancer risk—second cancellation tier	• Low and favorable intermediate risk—defer surgery • High risk—consider neoadjuvant therapy while awaiting surgery
Testicular	• Primary RPLND—low priority • Postchemo RPLND, stable mass—intermediate priority • Orchiectomy, growing postchemo mass RPLND—high priority	• Orchiectomy—last to be cancelled	N/A
Urethral/ Penile	• Tis/Ta/T1/low grade—intermediate priority • T2+/High grade—high priority	N/A	N/A